Effectiveness of repetitive Transcranial Magnetic Stimulation (rTMS) treatment in patients with chronic tinnitus.

Completed

• Conditions: phantom auditory perception; ringing in the ear; 10022396; 10042258

• Registration Number: NL-OMON31727
• Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 12 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 52

Inclusion Criteria

Chronic non fluctuating tinnitus, demonstrated tinnitus by means of the Diagnostic Protocol Tinnitus UMCU, without a treatable cause of at least two months duration
Age 18 years or older

Exclusion Criteria

Treatable cause of the tinnitus
Use of anticonvulsant drugs or psychotherapeutic drugs which lower the seizure threshold
History of epilepsy or family members with epilepsy
Presence of active migraine
Presence of structural brain changes
Presence of psychiatric disease
Presence of severe internal or heart diseases
Metal objects in or around body that cannot be removed
Metal workers
Pregnancy (will be tested on the first day of TMS with a urine pregnancy test)
Drugs or alcohol abuse
Prior treatment with TMS

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameter is the tinnitus severity measured by the Tinnitus<br /><br>Questionnaire. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The secondary study parameter investigates whether (in case of positive results<br /><br>with rTMS) tinnitus characteristics (frequency, loudness, minimal masking<br /><br>level, residual inhibition) change. The change in these tinnitus<br /><br>characteristics will be measured with the tinnitus analysis</p><br>